Marshall Wace LLP Invests $331,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)
Marshall Wace LLP acquired a new position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 80,431 shares of the company’s stock, valued at approximately $331,000. Marshall Wace LLP owned approximately 0.13% of Eledon Pharmaceuticals at the […]
